CompleWare Corporation
Pharmaceutical ManufacturingIowa, United States51-200 Employees
MERIT CRO, Inc., based in North Liberty, Iowa, operates in the pharmaceutical manufacturing space as a global provider of endpoint-related services for clinical development. It is the successor to CompleWare Corporation, and its activities cover multiple therapeutic areas, including ophthalmology within broader pharma and biotech ecosystems. The company serves the pharmaceutical and biotech sectors seeking support across the clinical development lifecycle. In 2026, MERIT CRO announced the establishment of MERIT CRO Australia, marking an expansion of its global operations. Leadership development is reflected by the 2024 appointment of a Chief Operating Officer. The firm positions itself as a mid-sized player in the pharmaceutical services sector with an expanding international footprint.